AnaCardio icon
AnaCardio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for heart failure. By harnessing cutting-edge science, AnaCardio aims to create novel drugs that enhance patient outcomes and transform heart failure treatment, addressing a critical need in cardiovascular healthcare.
National Ranking
743rd
in Sweden
Regional Ranking
17317th
in Western Europe
Global Ranking
68912th
worldwide
Rankings by SemRush